Age-related macular degeneration (AMD) is an eye disease that afflicts more than 9 million Americans - millions more worldwide – and it often results in severe vision loss. The Centers for Disease Control and Prevention (CDC) projects that the number of people 50 and older with early-stage AMD will nearly double to 17.8 million in the United States by 2050. Several companies have developed or are developing treatments to keep the condition from progressing. Such therapies could help with other diseases, as well.

“The retina’s accessible and a really good target,” said Ben Shaberman, an official at the Foundation Fighting Blindness. “If you get things to work in the retina, there’s a good chance you could apply them to neurodegenerative disorders of the brain or the central nervous system.”

The San Diego Center for the Blind can assist people with macular degeneration improve life quality; please contact us to learn more.

“Hope for new macular degeneration treatments buoys patients”